BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17846867)

  • 1. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.
    Alani AW; Robinson JR
    Pharm Res; 2008 Jan; 25(1):48-54. PubMed ID: 17846867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral absorption enhancement of cromolyn sodium through noncovalent complexation.
    Ding X; Rath P; Angelo R; Stringfellow T; Flanders E; Dinh S; Gomez-Orellana I; Robinson JR
    Pharm Res; 2004 Dec; 21(12):2196-206. PubMed ID: 15648250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Sodium
    Li Y; Yang D; Zhu C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.
    Brayden D; Creed E; O'Connell A; Leipold H; Agarwal R; Leone-Bay A
    Pharm Res; 1997 Dec; 14(12):1772-9. PubMed ID: 9453067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro.
    Leone-Bay A; Leipold H; Sarubbi D; Variano B; Rivera T; Baughman RA
    Pharm Res; 1996 Feb; 13(2):222-6. PubMed ID: 8932440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.
    Malkov D; Wang HZ; Dinh S; Gomez-Orellana I
    Pharm Res; 2002 Aug; 19(8):1180-4. PubMed ID: 12240944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
    Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
    J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium
    Li Y; Zhu C
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32340157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
    Qi R; Ping QN; Zhao W
    Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability.
    Patel RR; Chaurasia S; Khan G; Chaubey P; Kumar N; Mishra B
    J Microencapsul; 2016 May; 33(3):209-20. PubMed ID: 26885889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration Enhancement Strategies for Intradermal Delivery of Cromolyn Sodium.
    Holman M; Tijani A; Klein J; Frempong D; Dinh S; Puri A
    AAPS PharmSciTech; 2022 Jun; 23(6):171. PubMed ID: 35739411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
    Chiang PC; Deshmukh G; Liu J; Nagapudi K; Chen JZ; Valle N; Li R; Plise EG; Durk MR
    J Pharm Sci; 2020 Aug; 109(8):2629-2636. PubMed ID: 32360544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
    Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
    J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved delivery of cromolyn from oral proliposomal beads.
    Deshmukh DD; Ravis WR; Betageri GV
    Int J Pharm; 2008 Jun; 358(1-2):128-36. PubMed ID: 18400424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dodecylmaltoside (DDM) on uptake of BCS III compounds, tiludronate and cromolyn, in Caco-2 cells and rat intestine model.
    Deshmukh DD; Nagilla R; Ravis WR; Betageri GV
    Drug Deliv; 2010 Apr; 17(3):145-51. PubMed ID: 20136582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats.
    Qi R; Ping QN
    J Microencapsul; 2004 Feb; 21(1):37-45. PubMed ID: 14718184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
    Hess S; Rotshild V; Hoffman A
    Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.
    Baughman RA; Kapoor SC; Agarwal RK; Kisicki J; Catella-Lawson F; FitzGerald GA
    Circulation; 1998 Oct; 98(16):1610-5. PubMed ID: 9778325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
    Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
    Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and pharmacokinetic evaluation of a chemical delivery system for drug targeting to lung tissue.
    Saah M; Wu WM; Eberst K; Marvanyos E; Bodor N
    J Pharm Sci; 1996 May; 85(5):496-504. PubMed ID: 8742941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.